Until we bridge that perception gap, between data as ownership and data as collaboration, pre-competitive sharing will remain a nice idea that never scales.

Science doesn’t fail for lack of compute.
It fails for lack of connection.

#Biopharma #AI #OpenScience

It’s not a technical issue , it’s cultural.
We overestimate the value of isolated data and underestimate the power of shared context.

Most datasets lose their edge when they’re disconnected from the bigger picture. Still, everyone treats theirs as a moat.

find more details here- www.elucidata.io/datafair-2025

Strategic framework for leaders:

→ Core differentiators: Build / Co-build
→ Enabling technologies: Partner
→ Experimental capabilities: Partner first

Organizations planning to "build everything ourselves" are about to learn why platform economics always win.

What's your AI partnership strategy?

The consolidation wave starts now.

Shuttle-Molecule.ai acquisition signals what's coming.

The AI-pharma partnership landscape will get very concentrated, very fast.

Speed beats control.

While some debate "build vs. buy," winners deploy AI across value chains through partnerships.

Control is expensive. Speed is profitable.

Data network effects = new competitive moats.

Companies accessing the richest AI datasets create compound advantages.

Your proprietary data + their AI platform > your data + your basic AI.

Platform economics beat proprietary development.

Pharma giants choose specialized AI partners over in-house teams.

Why? Lower risk + faster deployment + cutting-edge capabilities.

In-house development can't compete with specialized focus.

Want to be part of one?
Mail us: elmarketing@elucidata.io

These are mismatched tools, fragmented workflows, opportunities lost in translation.

Moments like this help show what needs to change.

We want to keep doing this, building a community of people committed to making life-science R&D more connected, scalable, effective.

That sentence has stayed with me. Because behind every therapy, every discovery, are scientists fighting battles we rarely see. Not against biology alone - but against time.

4/4

#personalstory #CEO

At the end, she said something I’ll never forget:

👉 “For patients like me, all we have is hope. Hope that somewhere, some scientist is doing one more experiment that might help us.”

3/4

At a retreat during my time at Agios, our CEO invited a patient to share her story. She was a mom in her 30s, living with chronic anemia. Blood transfusions had shaped her entire life - through childhood and motherhood.

2/4